In terms of lymph node metastasis, in the N1 subgroup, patients with high PCAT6 expression had a significantly shorter OS than those with low PCAT6 expression, while no significant differences were observed between the N0 and N2 subgroups (Figure 2E‒G). Here, PCAT6 is linked to metastatic malignant neoplasm in the lymph nodes.